Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.

Author: Eun Ju CHOO ¹ ; Henry F CHAMBERS
Author Information

1. Division of Infectious Diseases, Department of Medicine, Soonchunhyang University Hospital, Bucheon, Korea.
Publication Type:Review
Keywords: Methicillin-resistant Staphylcoccus aureus; Vancomycin; Treatment
MeSH: Bacteremia*; Methicillin Resistance*; Methicillin-Resistant Staphylococcus aureus*; Vancomycin
From:Infection and Chemotherapy 2016;48(4):267-273
CountryRepublic of Korea
Language:English
Abstract: Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infections. Vancomycin remains an acceptable treatment option. There has been a welcome increase in the number of agents available for the treatment of MRSA infection. These drugs have certain differentiating attributes and may offer some advantages over vancomycin, but they also have significant limitations. These agents provide some alternative when no other options are available.